Biomarkers for inflammatory bowel disease: current updates and future outlook
10.3760/cma.j.issn.1009-9158.2018.10.003
- VernacularTitle:炎症性肠病生物标志物的研究进展
- Author:
Wenhao WENG
1
;
Yin LONG
;
Weijie PAN
Author Information
1. 同济大学附属杨浦医院检验科
- Keywords:
Inflammatory bowel diseases;
Biomarkers
- From:
Chinese Journal of Laboratory Medicine
2018;41(10):712-715
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory bowel diseases ( IBD) includes ulcerative colitis ( UC) and Crohn′s disease (CD).Recently, the incidence of IBD in China has been growing rapidly and caused a major public health burden.Although several traditional diagnostic methods can directly evaluate intestinal inflammation in patients with IBD , there are still limitations in these methods such as invasive or unreliable results because of clinical and pathologists′clinical experience .Therefore, there is urgent need for non-invasive, objective and reliable tool for IBD diagnosis or monitoring .With the development of technology and understanding of the pathogenesis of IBD , much progress has been achieved to discover novel IBD biomarkers in genetic , microecological , metabolomics and gut barrier field .In this review , we will demonstrate current updates of IBD related biomarkers and showed future prospective of these biomarkers .
